MERGA DIVISION
Edanus® Injection Specialist Neurological Care
PRODUCT OVERVIEW
Understanding EDANUS® Injection
The formulation’s clinical role depends on the approved indication, current prescribing information, and individual patient assessment. Its use should be guided by qualified healthcare professionals in accordance with applicable prescribing recommendations.
Composition & Therapeutic Profile
EDANUS® Injection features edaravone, an active pharmaceutical ingredient with free-radical-scavenging properties. Its therapeutic application depends on the approved indication and the clinical assessment of qualified healthcare professionals.
Composition
Edaravone Injection JP
Therapeutic Class
Free-Radical Scavenger
Therapeutic Focus
Specialist Neurological Care
How Edaravone Works Against Oxidative Stress
Oxidative stress occurs when reactive molecules exceed the body’s antioxidant defences and can contribute to cellular damage. Edaravone’s pharmacological activity provides the basis for its use in certain approved neurological indications.
Its clinical relevance depends on the specific indication, approved prescribing information, and assessment by qualified healthcare professionals.
Therapeutic Focus in Neurological Care
EDANUS® Injection contains edaravone and is intended for use in specific neurological conditions according to its approved indications. Its clinical application should be determined by qualified healthcare professionals based on the applicable prescribing information and individual patient assessment.
Specialist Neurological Care
For neurological conditions where edaravone is specifically indicated.
Indication-Specific Use
Clinical use guided by approved prescribing information and medical assessment.
Responsible Clinical Practice
Use under qualified medical supervision for approved indications only.
Frequently Asked Questions
EDANUS is an edaravone injection intended for specialist neurological care.
It is administered by healthcare professionals according to the approved indication and dosing information.
No. Suspected stroke requires urgent emergency assessment and standard stroke-care pathways.
Do not self-administer. Use must follow the approved instructions and be managed by qualified healthcare professionals.
Discover Our Specialty Pharmaceutical Portfolio
Explore the MERGA and PRINCEPS divisions of Seginus Pharma and discover our portfolio of pharmaceutical products across key therapeutic areas.
